Got a stuffy nose and a cough? If you go to an urgent care or ER, chances are that you may be able find out exactly what type of germ is making you sick, thanks to newer tests that don’t look for just ...

Please provide your email address to receive an email when new articles are posted on . “Contrary to the initial intentions of the multiplex assay, our study demonstrates that the inherent advantages ...

Hologic is acquiring molecular diagnostics firm Mobidiag Oy in an approximately $795 million deal that will give the women’s health company the capability to offer testing closer to patients with ...

The "Molecular Diagnostics for Infectious Disease – Market Forecasts, Strategies and Trends – By Syndrome and by Country – With Multiplex and Point of Care Market Analysis, Executive Guides and ...

Claims for unregulated rapid molecular diagnostic tests for urinary tract infections (UTIs) in older adults have soared 60-fold from 2016 to 2023, according to Medicare data. The rise was most ...

The system is intended for use in urgent care clinics, primary care settings, physician office laboratories, and pharmacies.

QIAGEN’s NeuMoDx test has received emergency use authorization from the U.S. Food and Drug Administration (FDA). The test helps to quickly identify and differentiate individuals suspected of ...

QIAGEN N.V. QGEN recently received Emergency Use Authorization (EUA) from the FDA for the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Assay. Notably, the polymerase chain reaction (PCR) multiplex test will ...

Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer Although predictive multiplex somatic ...